Shuling Wu

715 total citations
31 papers, 560 citations indexed

About

Shuling Wu is a scholar working on Immunology, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Shuling Wu has authored 31 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Pathology and Forensic Medicine and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Shuling Wu's work include Immune Cell Function and Interaction (6 papers), Acute Lymphoblastic Leukemia research (6 papers) and Lymphoma Diagnosis and Treatment (4 papers). Shuling Wu is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Acute Lymphoblastic Leukemia research (6 papers) and Lymphoma Diagnosis and Treatment (4 papers). Shuling Wu collaborates with scholars based in Germany, China and Taiwan. Shuling Wu's co-authors include Beate Tebbe, Constantin E. Orfanos, Vitam Kodelja, Jürgen Eberle, Karl Seeger, Reinhard Geßner, Arend von Stackelberg, Alexander Korte, Deng-Chyang Wu and Günter Henze and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Shuling Wu

29 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuling Wu Germany 15 137 122 77 73 70 31 560
Jing Wen China 15 203 1.5× 218 1.8× 94 1.2× 23 0.3× 65 0.9× 62 780
Aimilia D. Sklirou Greece 19 113 0.8× 295 2.4× 36 0.5× 23 0.3× 163 2.3× 38 1.0k
Ali H. Ad’hiah Iraq 13 203 1.5× 80 0.7× 22 0.3× 32 0.4× 71 1.0× 109 666
Wen Xiong China 16 172 1.3× 306 2.5× 23 0.3× 36 0.5× 44 0.6× 48 860
Thomas K. Petersen Denmark 15 192 1.4× 224 1.8× 23 0.3× 130 1.8× 44 0.6× 34 857
Akemi YAMAMOTO Japan 14 128 0.9× 117 1.0× 19 0.2× 168 2.3× 51 0.7× 70 646
Drora Halperin Israel 16 161 1.2× 326 2.7× 28 0.4× 24 0.3× 126 1.8× 24 757
Yasushi Iwaoka Japan 9 277 2.0× 137 1.1× 57 0.7× 17 0.2× 36 0.5× 18 1.0k
Takashi Kurata Japan 13 64 0.5× 138 1.1× 33 0.4× 14 0.2× 92 1.3× 53 472
Kyoko Ueda Japan 12 87 0.6× 262 2.1× 26 0.3× 18 0.2× 215 3.1× 46 817

Countries citing papers authored by Shuling Wu

Since Specialization
Citations

This map shows the geographic impact of Shuling Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuling Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuling Wu more than expected).

Fields of papers citing papers by Shuling Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuling Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuling Wu. The network helps show where Shuling Wu may publish in the future.

Co-authorship network of co-authors of Shuling Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Shuling Wu. A scholar is included among the top collaborators of Shuling Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuling Wu. Shuling Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Shuling, et al.. (2024). Spermidine enhances parthenocarpic fruit formation in cucumber by promoting efficient distribution of soluble sugars and photosynthates. Scientia Horticulturae. 330. 113103–113103. 2 indexed citations
2.
Cao, Weihua, Tingting Jiang, Shiyu Wang, et al.. (2024). Insulin resistance has closer correlation with the occurrence of metabolic dysfunction associated steatotic liver disease diagnosed by liver biopsy. Frontiers in Medicine. 11. 1384927–1384927. 1 indexed citations
4.
Cheng, Jason Chia‐Hsien, Min-Shu Hsieh, Pei‐Ming Huang, et al.. (2024). Adjuvant chemoradiotherapy plus pembrolizumab for locally advanced esophageal squamous cell carcinoma with high risk of recurrence following neoadjuvant chemoradiotherapy: a single-arm phase II study. Cancer Immunology Immunotherapy. 73(11). 230–230. 2 indexed citations
5.
Wu, Shuling, et al.. (2020). The study of neuroprotective effects and underlying mechanism of Naoshuantong capsule on ischemia stroke mice. Chinese Medicine. 15(1). 119–119. 15 indexed citations
6.
Chen, Pan, Hongliang Yao, Weiwei Su, et al.. (2020). Pharmacodynamic and Metabolomics Studies on the Effect of Kouyanqing Granule in the Treatment of Phenol-Induced Oral Ulcer Worsened by Sleep Deprivation. Frontiers in Pharmacology. 11. 824–824. 12 indexed citations
8.
Wu, Shuling, et al.. (2018). Intensive care unit-acquired complicated necrotizing pneumonia caused by <i>Enterobacter cloacae</i>: A case report. Intractable & Rare Diseases Research. 7(4). 283–286. 3 indexed citations
9.
Lin, Qunying, et al.. (2018). Antioxidant Activity of Water Extract from Fermented Mycelia of Cordyceps sobolifera (Ascomycetes) in Caenorhabditis elegans. International journal of medicinal mushrooms. 20(1). 61–70. 11 indexed citations
10.
Wu, Shuling, et al.. (2016). Septic Pulmonary Embolism Requiring Critical Care: Clinicoradiological Spectrum, Causative Pathogens and Outcomes. Clinics. 71(10). 562–569. 27 indexed citations
12.
Wu, Shuling, et al.. (2008). IL-8 production and AP-1 transactivation induced by UVA in human keratinocytes: Roles of d-α-tocopherol. Molecular Immunology. 45(8). 2288–2296. 34 indexed citations
13.
Wu, Shuling, Reinhard Geßner, Tillmann Taube, et al.. (2006). Chemokine IL-8 and Chemokine Receptor CXCR3 and CXCR4 Gene Expression in Childhood Acute Lymphoblastic Leukemia at First Relapse. Journal of Pediatric Hematology/Oncology. 28(4). 216–220. 16 indexed citations
14.
Weimann, Andreas, et al.. (2006). Novel two‐stage screening procedure leads to the identification of a new class of transfection enhancers. The Journal of Gene Medicine. 8(6). 745–753. 4 indexed citations
15.
Wu, Shuling, et al.. (2005). Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia. Cancer. 103(5). 1054–1063. 41 indexed citations
16.
Wu, Shuling, et al.. (2004). Interaction of bone marrow stromal cells with lymphoblasts and effects of predinsolone on cytokine expression. Leukemia Research. 29(1). 63–72. 18 indexed citations
17.
18.
Korte, Alexander, Joachim Köchling, Cornelia Eckert, et al.. (2000). EXPRESSION ANALYSIS AND CHARACTERIZATION OF ALTERNATIVELY SPLICED TRANSCRIPTS OF HUMAN IL-7Rα CHAIN ENCODING TWO TRUNCATED RECEPTOR PROTEINS IN RELAPSED CHILDHOOD ALL. Cytokine. 12(11). 1597–1608. 23 indexed citations
19.
Chen, Mei-Ju, Yuan‐Yow Chiou, Deng-Chyang Wu, & Shuling Wu. (2000). Lifestyle habits and gastric cancer in a hospital-based case-control study in Taiwan. The American Journal of Gastroenterology. 95(11). 3242–3249. 37 indexed citations
20.
Tebbe, Beate, et al.. (1997). L-Ascorbic Acid Inhibits UVA-Induced Lipid Peroxidation and Secretion of IL-1α and IL-6 in Cultured Human Keratinocytes In Vitro. Journal of Investigative Dermatology. 108(3). 302–306. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026